Product
Allogeneic Human Mesenchymal Stem Cells
2 clinical trials
3 indications
Indication
Dilated CardiomyopathyIndication
Major Depressive DisorderIndication
Alcohol Use DisorderClinical trial
A Phase IIB Randomized, Placebo-Controlled, Multicenter Study of the Comparative Efficacy and Safety of Administration of Allogeneic-MSC Versus Placebo in Patients With Non- Ischemic Dilated CardiomyopathyStatus: Recruiting, Estimated PCD: 2025-12-01